Strategies for simultaneous and successive delivery of RNA
Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost...
Gespeichert in:
Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2020-12, Vol.98 (12), p.1767-1779 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1779 |
---|---|
container_issue | 12 |
container_start_page | 1767 |
container_title | Journal of molecular medicine (Berlin, Germany) |
container_volume | 98 |
creator | Moradian, Hanieh Lendlein, Andreas Gossen, Manfred |
description | Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level. |
doi_str_mv | 10.1007/s00109-020-01956-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7679312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473255961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-9ce97ea7286a44f5f2946453ef4ed7649e84438fbbf46c42c107c0c3455b53203</originalsourceid><addsrcrecordid>eNp9kUlPwzAQhS0EgrL8AQ4oEhcuAS9ju-aAhBCbVIHEcrZSd1yC0qTYCVL_PS5hP3Caw3zz5j09QnYZPWSU6qNIKaMmp5zmlBmpcrZCBgwEzxkAXSUDakDlXDO1QTZjfE64lgbWyYYQDJQGGJDj-zYULU5LjJlvQhbLWVe1RY1NF7OinmSxcw5jLF8xm2CVRlhkjc_ubk63yZovqog7H3OLPF6cP5xd5aPby-uz01HuQEObG4dGY6H5UBUAXnqeXIEU6AEnWoHBIYAY-vHYg3LAHaPaUSdAyrEUnIotctLrzrvxDCcO62S5svNQzoqwsE1R2t-bunyy0-bVaqWNYDwJHHwIhOalw9jaWRkdVlUf03KQCQVhIKH7f9Dnpgt1ipcoLbiURrFE8Z5yoYkxoP8yw6hdVmP7amyqxr5XY5dHez9jfJ18dpEA0QMxreophu_f_8i-AfikmNA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473255961</pqid></control><display><type>article</type><title>Strategies for simultaneous and successive delivery of RNA</title><source>SpringerLink (Online service)</source><creator>Moradian, Hanieh ; Lendlein, Andreas ; Gossen, Manfred</creator><creatorcontrib>Moradian, Hanieh ; Lendlein, Andreas ; Gossen, Manfred</creatorcontrib><description>Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-020-01956-1</identifier><identifier>PMID: 33146744</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Efficiency ; Gene expression ; Gene transfer ; Human Genetics ; Internal Medicine ; Molecular Medicine ; Original ; Original Article ; siRNA ; Transfection</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2020-12, Vol.98 (12), p.1767-1779</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-9ce97ea7286a44f5f2946453ef4ed7649e84438fbbf46c42c107c0c3455b53203</citedby><cites>FETCH-LOGICAL-c474t-9ce97ea7286a44f5f2946453ef4ed7649e84438fbbf46c42c107c0c3455b53203</cites><orcidid>0000-0002-1761-4063</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-020-01956-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-020-01956-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,315,781,785,886,27926,27927,41490,42559,51321</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33146744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moradian, Hanieh</creatorcontrib><creatorcontrib>Lendlein, Andreas</creatorcontrib><creatorcontrib>Gossen, Manfred</creatorcontrib><title>Strategies for simultaneous and successive delivery of RNA</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Efficiency</subject><subject>Gene expression</subject><subject>Gene transfer</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Molecular Medicine</subject><subject>Original</subject><subject>Original Article</subject><subject>siRNA</subject><subject>Transfection</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kUlPwzAQhS0EgrL8AQ4oEhcuAS9ju-aAhBCbVIHEcrZSd1yC0qTYCVL_PS5hP3Caw3zz5j09QnYZPWSU6qNIKaMmp5zmlBmpcrZCBgwEzxkAXSUDakDlXDO1QTZjfE64lgbWyYYQDJQGGJDj-zYULU5LjJlvQhbLWVe1RY1NF7OinmSxcw5jLF8xm2CVRlhkjc_ubk63yZovqog7H3OLPF6cP5xd5aPby-uz01HuQEObG4dGY6H5UBUAXnqeXIEU6AEnWoHBIYAY-vHYg3LAHaPaUSdAyrEUnIotctLrzrvxDCcO62S5svNQzoqwsE1R2t-bunyy0-bVaqWNYDwJHHwIhOalw9jaWRkdVlUf03KQCQVhIKH7f9Dnpgt1ipcoLbiURrFE8Z5yoYkxoP8yw6hdVmP7amyqxr5XY5dHez9jfJ18dpEA0QMxreophu_f_8i-AfikmNA</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Moradian, Hanieh</creator><creator>Lendlein, Andreas</creator><creator>Gossen, Manfred</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1761-4063</orcidid></search><sort><creationdate>20201201</creationdate><title>Strategies for simultaneous and successive delivery of RNA</title><author>Moradian, Hanieh ; Lendlein, Andreas ; Gossen, Manfred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-9ce97ea7286a44f5f2946453ef4ed7649e84438fbbf46c42c107c0c3455b53203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Efficiency</topic><topic>Gene expression</topic><topic>Gene transfer</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Molecular Medicine</topic><topic>Original</topic><topic>Original Article</topic><topic>siRNA</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moradian, Hanieh</creatorcontrib><creatorcontrib>Lendlein, Andreas</creatorcontrib><creatorcontrib>Gossen, Manfred</creatorcontrib><collection>Springer_OA刊</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moradian, Hanieh</au><au>Lendlein, Andreas</au><au>Gossen, Manfred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategies for simultaneous and successive delivery of RNA</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>98</volume><issue>12</issue><spage>1767</spage><epage>1779</epage><pages>1767-1779</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33146744</pmid><doi>10.1007/s00109-020-01956-1</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-1761-4063</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0946-2716 |
ispartof | Journal of molecular medicine (Berlin, Germany), 2020-12, Vol.98 (12), p.1767-1779 |
issn | 0946-2716 1432-1440 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7679312 |
source | SpringerLink (Online service) |
subjects | Biomedical and Life Sciences Biomedicine Efficiency Gene expression Gene transfer Human Genetics Internal Medicine Molecular Medicine Original Original Article siRNA Transfection |
title | Strategies for simultaneous and successive delivery of RNA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T21%3A48%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategies%20for%20simultaneous%20and%20successive%20delivery%20of%20RNA&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Moradian,%20Hanieh&rft.date=2020-12-01&rft.volume=98&rft.issue=12&rft.spage=1767&rft.epage=1779&rft.pages=1767-1779&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-020-01956-1&rft_dat=%3Cproquest_pubme%3E2473255961%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473255961&rft_id=info:pmid/33146744&rfr_iscdi=true |